Skip to content
WeighLab
Menu
Ranked #233 · Grade C

Arc-1 review

Arc-1 offers compounded semaglutide (from $249.99) and compounded tirzepatide (from $299.99) as per-dose purchases, not monthly subscriptions.

Visit Arc-1 Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$200/mo (0.5 mg dose, compounded)
Tirzepatide
$200/mo (2.5 mg dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Semaglutide · modeled / year

$2,400

Tirzepatide · modeled / year

$2,400

The Index scorecard

Arc-1 scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month56/100
Price Transparency86/100
Nationwide Access24/100
Formulation Options66/100
Clinical Oversight72/100
Contract Flexibility61/100

Where the value is

  • Both compounded semaglutide and tirzepatide available
  • Per-dose purchasing — no subscription or membership required
  • 25% off plus free shipping promotion
  • Broader longevity formulary (rapamycin, NAD+, sermorelin)
  • LegitScript Certified badge now displayed on product pages

The tradeoffs

  • No legal entity name or address disclosed
  • State availability not disclosed
  • No named clinicians or pharmacy partners
  • Per-dose pricing still climbs with dose (semaglutide 2.5mg is $549.99/mo, tirzepatide 7.5mg $399.99/mo)

The bottom line

Best for: Patients seeking per-dose compounded GLP-1 without subscriptions. Arc-1 offers compounded semaglutide (from $249.99) and compounded tirzepatide (from $299.99) as per-dose purchases, not monthly subscriptions.

Ranked #233 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Arc-1.

The 18 programs nearest this one

Pricing, states and verification reflect Arc-1's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Arc-1's site. Not medical advice; see our disclosure.

← Back to the value leaderboard